Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Observational
SUMMARY
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3);
• Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography
• Agree to participate in the study and sign the informed consent form.
Locations
Other Locations
China
Peking University Third Hospital
RECRUITING
Beijing
Contact Information
Primary
Yu Fu
lilac_fu@126.com
13671185050
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 330
Treatments
Conservative group
Don't use antiplatelet drugs or undergo patent foramen ovale closure.
Antiplatelet group
The application of antiplatelet drug.
PFO group
Receive a patent foramen ovale closure surgery.
Related Therapeutic Areas
Sponsors
Leads: Peking University Third Hospital